Medical Director CVPath Assoc. Professor University Of Maryland School of Medicine
Cardiology
Dr. Aloke V. Finn, MD
|
|
Give Review
Doctor Aloke V. Finn, MD is an expert in the field of Cardiology. He went to Vanderbilt University School of Medicine. Aloke V. Finn, MD is also published. He has 100 publications published. The lastest publication: "The role of tyrosine kinases and map kinases in LPS-induced signaling.' He is registered with Medicare.
Publications
- The clinical challenge of disappearing stents.
- Pathophysiology of native Coronary, vein graft, and in-stent atherosclerosis.
- Embolic Myocardial Infarction as a Consequence of Atrial Fibrillation: A Prevailing Disease of the Future.
- Illuminating Culprit Plaque Histology by Optical Coherence Tomography: Shedding New Light on Old Insights.
- Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration.
- Causes of early stent thrombosis in patients presenting with Acute coronary syndrome: an ex vivo human autopsy study.
- Everolimus-Eluting Stents Improve Vascular Response in a Diabetic Animal Model.
- Evaluating the vascular response of bioabsorbable polymer drug-eluting stents in atherosclerosis.
- 2-deoxy-2-[(18)F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis.
- Computational Fluid Dynamics Simulations of Hemodynamics in Plaque Erosion.
- Clinical and Angiographic Results After Hybrid Coronary Revascularization.
- Comparison of pathology of chronic total occlusion with and without Coronary artery bypass graft.
- A comprehensive Acute coronary syndrome algorithm for centers with percutaneous coronary intervention capability.
- Metformin impairs endothelialization after placement of Newer Generation Drug Eluting Stents.
- Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics.
- Sirolimus-FKBP12.6 Impairs Endothelial Barrier Function Through Protein Kinase C-α Activation and Disruption of the p120-VE Cadherin Interaction.
- Histopathologic characteristics of atherosclerotic Coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques.
- Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted Mammalian target of rapamycin inhibitors via s6 kinase-dependent...
- Do vulnerable and ruptured plaques hide in heavily calcified arteries?
- Lessons learned from robotic-assisted Coronary artery bypass surgery: risk factors for conversion to median sternotomy.
- Ex vivo assessment of vascular response to Coronary stents by optical frequency domain imaging.
- Hemoglobin Directs Macrophage Differentiation and Prevents Foam Cell Formation in Human Atherosclerotic Plaques.
- Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis.
- Microvascular Obstruction Is Caused by Atherothrombosis in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
- Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.
- IVUS and OCT: Either or Survivor ???.
- Bibliographic Metrics at JACC: Cardiovascular Imaging An Opportunity for Audit and Reflection.
- Autopsy validation study of the academic research consortium stent thrombosis definition.
- The pathology of neoatherosclerosis in human Coronary implants bare-metal and drug-eluting stents.
- Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.
- The differences between neovascularization of Chronic total occlusion and intraplaque angiogenesis.
- Concept of vulnerable/unstable plaque.
- Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation.
- Letter by Virmani et al regarding article, "Drug-eluting stents in animals and patients: where do we stand today?".
- Seeking alternatives to Hard End Points: is imaging the best APPROACH?
- Correlation between Carotid intimal/medial thickness and atherosclerosis: a point of view from pathology.
- Coronary plaque neovascularization and hemorrhage: a potential target for plaque stabilization?
- Incidence and predictors of drug-eluting stent fracture in human Coronary artery a pathologic analysis.
- Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: require...
- Do we really understand pimecrolimus?
- One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.
- Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?
- Predictive factors for in-stent late loss and Coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo.
- Carotid plaque stabilization and progression after stroke or TIA.
- Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
- Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis.
- Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.
- Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for Acute myocardial infarction patients: an autopsy s...
- Prosthetic valve dysfunction presenting as intermittent Acute aortic regurgitation.
- Endothelial cell recovery between comparator polymer-based drug-eluting stents.
- Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation?
- Drug-eluting stent implantation may not affect vasomotor function in early phase.
- Culprit plaque in Myocardial infarction going beyond angiography.
- The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
- Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human Coronary arteries: a pathologic study.
- Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
- Vascular responses to drug eluting stents: importance of delayed healing.
- Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?
- Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
- Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.
- Controversies surrounding the use of drug-eluting stents.
- Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
- Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.
- Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.
- Picking plaques that pop ...
- Drug-eluting stents for diabetes mellitus: a rush to judgment?
- One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus.
- Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of Coronary art...
- Intraplaque hemorrhage and progression of Coronary atheroma.
- Images in clinical medicine. Isolated right ventricular Infarction.
- The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis.
- Cxc chemokine receptor expression on human endothelial cells.
- [A novel questionnaire to assess activity in patients after hip arthroplasties].
- Production and characterization of antibodies for the specific determination of the opioid peptide Met5-Enkephalin-Arg6-Phe7.
- A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
- Sensory neuropeptidergic pattern in tendon, ligament and joint capsule. A study in the rat.
- Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
- The significance of interleukin 8 in urine.
- The role of tyrosine kinases and map kinases in LPS-induced signaling.
- Chemokine receptors and their role in vascular biology.
- Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy.
- Safety of a new conjugate meningococcal C vaccine in infants.
- Germline incorporation of a replication-Defective adenoviral vector in mice does not alter immune responses to adenoviral vectors.
- Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins.
- Coronary stent assessability by 64 slice multi-detector computed tomography.
- Pathologic assessment of the vulnerable human Coronary plaque.
- Vascular remodeling after Coronary stent implantation.
- The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to Acute coronary syndromes.
- A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic Diseases.
- Identification of intracellular pathways through which TGF-beta1 upregulates PAI-1 expression in endothelial cells.
- Vascular pathology of drug-eluting stents.
- Virtual histology: does it add anything?
- Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.
- Total erythrocyte membrane cholesterol: a marker of plaque instability?
- Drug-eluting stent pathology--should we still be cautious?
- Drug-eluting stent safety: findings from preclinical studies.
- Pathology of drug-eluting stents: implications for Coronary intervention.
- A review of current devices and a look at new technology: drug-eluting stents.
- Pathophysiology of vascular healing and stent mediated arterial injury.
Schools
Vanderbilt University School Of Medicine
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Vanderbilt University School of Medicine
Hospital
-
Emory University Hospital Midtown -
Emory University Hospital
Drug Facts
| NPI NUMBER | 1417922147 | |
| NPPES Provider LastName | FINN | |
| NPPES Provider FirstName | ALOKE | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 686.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417922147 |
| Last Name Of The Provider | FINN |
| First Name Of The Provider | ALOKE |
| View All |
Similar Doctors
|
|
Dr. Shiyin Foo, MD |
|
|
Dr. Varsha K. Tanguturi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward T. Carreras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane S. Bae, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jae B. Kim, MD |
|
|
Dr. Meredith J. Rooney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc J. Semigran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne Valente, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danel E. Forman, MD |
|
|
Dr. Alfred J. Albano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Advay G. Bhatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samy Selim, MD
This Doctor is OpenDoctor Recommended.
|